Loading institutional data...
Loading institutional data...
Strong institutional accumulation: ownership increased +8.61% quarter-over-quarter.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $11.96 today, the market must believe free cash flow compounds -51.5%/yr for a decade (off $53M normalized FCF).
The market's -51.5% is more conservative than its 9-yr track record.
2-stage DCF · 0.01B shares · net debt -$89M
mean 19.5% · volatility σ 94% · implied rate exceeded in 6/9 yrs
Central path = implied -51.5%/yr growth; shaded band = ±1σ (94%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
4/8 of the 9 checks — 1 couldn't be scored (see above), so the score is out of the 8 with data.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Needs granular two-year detail (receivables, PP&E, D&A, SG&A) — not fully reported.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Coverage data unavailable.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
The dividend is comfortably covered — only 16% of free cash flow, leaving room to grow it and fund buybacks. Last year: $195000 dividends + $0 buybacks = $195000 returned on $1M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A cash-return story — far more went to shareholders than back into the business (mature, low-reinvestment).
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: -9%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $89M covers all $3M of scheduled principal — no refinancing pressure. Scheduled principal only (excludes interest & revolver draws). As of 2012-12-31 (10-K).
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest expense isn't separately reported — often netted into “other income (expense), net.”
Cash vs short-term debt unavailable.
Short-term / long-term split not separately reported.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $385.8M 100.0% | $602.5M 100.0% | $1.07B 100.0% | $1.60B 100.0% | $1.53B 100.0% | $934.8M 100.0% | $713.7M 100.0% | $501.0M 100.0% | $301.6M 100.0% | $274.5M 100.0% |
| Cost of Revenue | $110.6M 28.7% | $157.8M 26.2% | $296.2M 27.6% | $458.2M 28.7% | $398.5M 26.1% | $237.0M 25.4% | $176.8M 24.8% | $121.1M 24.2% | $73.8M 24.5% | $68.9M 25.1% |
| Gross Profit | $275.2M 71.3% | $444.6M 73.8% | $775.9M 72.4% | $1.14B 71.3% | $1.13B 73.9% | $697.8M 74.6% | $536.9M 75.2% | $379.9M 75.8% | $227.8M 75.5% | $205.7M 74.9% |
| Research & Development | $4.3M 1.1% | $4.6M 0.8% | $4.6M 0.4% | $4.5M 0.3% | $4.4M 0.3% | $2.8M 0.3% | $2.7M 0.4% | $2.2M 0.4% | $1.5M 0.5% | $2.0M 0.7% |
| Selling, General & Admin | $289.4M 75.0% | $441.7M 73.3% | $649.4M 60.6% | $955.6M 59.8% | $911.4M 59.7% | $563.7M 60.3% | $445.8M 62.5% | $310.8M 62.0% | $188.2M 62.4% | $178.8M 65.1% |
| Operating Income | -$14.2M -3.7% | $2.9M 0.5% | $126.4M 11.8% | $184.8M 11.6% | $216.2M 14.2% | $134.2M 14.4% | $91.0M 12.8% | $69.1M 13.8% | $39.6M 13.1% | $26.9M 9.8% |
| Other Income (Expense), net | $8.6M 2.2% | $909K 0.2% | $2.4M 0.2% | -$747K -0.0% | -$112K -0.0% | $106K 0.0% | $1.3M 0.2% | $1.5M 0.3% | $694K 0.2% | $263K 0.1% |
| Pretax Income | -$5.6M -1.5% | $3.8M 0.6% | $128.8M 12.0% | $184.1M 11.5% | $216.1M 14.2% | $134.3M 14.4% | $92.4M 12.9% | $70.5M 14.1% | $40.3M 13.4% | $27.1M 9.9% |
| Income Tax Expense | $13.0M 3.4% | $1.7M 0.3% | $29.4M 2.7% | $40.5M 2.5% | $52.1M 3.4% | $31.4M 3.4% | $14.4M 2.0% | $14.8M 2.9% | $12.6M 4.2% | $9.3M 3.4% |
| Net Income | -$19.0M -4.9% | $2.0M 0.3% | $99.0M 9.2% | $144.0M 9.0% | $164.0M 10.7% | $102.9M 11.0% | $77.9M 10.9% | $55.8M 11.1% | $27.7M 9.2% | $17.8M 6.5% |
| Per Share | ||||||||||
| EPS (Basic) | $-1.70 | $0.19 | $9.13 | $12.82 | $14.01 | $8.74 | $6.62 | $4.67 | $2.32 | $1.51 |
| EPS (Diluted) | $-1.70 | $0.19 | $9.10 | $12.73 | $13.89 | $8.68 | $6.43 | $4.62 | $2.29 | $1.49 |
| Weighted Avg Shares (Basic) | 11.0M | 10.9M | 10.9M | 11.2M | 11.7M | 11.8M | 11.8M | 11.9M | 11.9M | 11.8M |
| Weighted Avg Shares (Diluted) | 11.0M | 11.0M | 10.9M | 11.3M | 11.8M | 11.8M | 12.1M | 12.1M | 12.1M | 11.9M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
EOD close · as of 2026-09-17
Where each multiple sits in its own 14-yr range · 40th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 16.5× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 24.2 | 24.8 | 25.4 | 26.1 | 28.7 | 27.6 | 26.2 | 28.7 |
| Gross Profit | 75.8 | 75.2 | 74.6 | 73.9 | 71.3 | 72.4 | 73.8 | 71.3 |
| R&D | 0.4 | 0.4 | 0.3 | 0.3 | 0.3 | 0.4 | 0.8 | 1.1 |
| SG&A | 62.0 | 62.5 | 60.3 | 59.7 | 59.8 | 60.6 | 73.3 | 75.0 |
| Operating Income | 13.8 | 12.8 | 14.4 | 14.2 | 11.6 | 11.8 | 0.5 | -3.7 |
| Income Tax | 2.9 | 2.0 | 3.4 | 3.4 | 2.5 | 2.7 | 0.3 | 3.4 |
| Net Income | 11.1 | 10.9 | 11.0 | 10.7 | 9.0 | 9.2 | 0.3 | -4.9 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on MED: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Ranked against 490 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AMZN | $2.65T | — | — | — | — | — | — | 20.5% | 16.2% | — | 5,764 |
| TSLA | $1.34T | 331.6× | 142.2× | 14.2× | -2.9% | 18.0% | 4.0% | 4.6% | 4.2% | 0.9× | 4,029 |
| TM | $608.8B | 59.5× | 24.6× | 2.6× | 3.8% | 18.4% | 4.4% | 7.9% | 5.9% | 1.7× | 665 |
| PDD | $448.4B | 33.4× | 32.3× | 7.3× | 14.5% | 56.3% | 22.7% | 23.7% | 23.7% | — | 548 |
| HD | $301.3B | 21.3× | 14.3× | 1.8× | 3.2% | 33.3% | 8.6% | 110% | 22.8% | 2.0× | 3,970 |
| BABA | $199.3B | 134.1× | — | 1.3× | 8.1% | 39.8% | 10.1% | 9.8% | 9.8% | — | 1,298 |
| TJX | $136.0B | 25.2× | — | 2.3× | 7.1% | 31.0% | 9.1% | 53.9% | 42.1% | — | 2,608 |
| HTHT | $131.2B | 185.7× | 113.0× | — | — | — | — | 39.7% | 27.3% | 0.7× | 258 |
| SBUX | $110.7B | 59.7× | 26.9× | 3.0× | 2.8% | — | 5.0% | -22.9% | 23.3% | 3.4× | 2,252 |
| LOW | $108.9B | 16.4× | 12.0× | 1.3× | 3.1% | 33.5% | 7.7% | -67.1% | 22.3% | 3.2× | 2,591 |
| ABNB | $102.7B | — | 38.3× | 8.4× | 10.3% | 83.0% | 20.5% | 30.6% | 24.6% | 0.8× | 1,246 |
| MELI | $93.3B | 46.7× | — | 3.2× | 39.1% | 44.5% | 6.9% | 29.6% | 12.5% | — | 1,380 |
| MAR | $89.1B | 35.2× | 20.7× | 3.4× | 4.3% | — | 9.9% | -69.0% | -69.4% | 0.0× | 1,559 |
| LKNCY | $87.3B | 170.2× | 91.9× | 12.4× | 48.9% | — | 7.3% | 23.0% | 23.0% | — | 9 |
| GM | $76.2B | 25.8× | 3.7× | 0.4× | -1.3% | — | 1.5% | 4.4% | 4.4% | — | 1,447 |
| ROST | $72.5B | 34.0× | 21.6× | 3.2× | 7.7% | 27.7% | 9.4% | 34.7% | 27.8% | 0.5× | 1,276 |
| ORLY | $70.5B | 28.2× | 19.2× | 4.0× | 6.4% | 51.6% | 14.3% | -333% | 48.3% | 1.5× | 1,569 |
| HLT | $70.4B | 49.9× | 24.2× | 5.8× | 7.7% | — | 12.1% | -27.0% | -27.0% | — | 1,126 |
| RCL | $68.8B | 16.3× | — | 3.8× | 8.8% | 49.4% | 23.8% | 42.5% | 32.3% | — | 1,114 |
| SE | $63.4B | 41.1× | 25.1× | 2.8× | 36.4% | 44.7% | 6.9% | 12.6% | 12.6% | — | 718 |
| F | $53.1B | — | 4.4× | 0.3× | 1.2% | 6.8% | -4.4% | -22.7% | -22.7% | — | — |
| NKE | $53.1B | 17.0× | — | 1.1× | 0.2% | 42.9% | 6.7% | 20.9% | 13.6% | — | 1,848 |
| EBAY | $49.0B | 25.1× | 17.8× | 4.4× | 7.9% | 71.5% | 18.3% | 45.3% | 38.8% | 0.3× | 1,182 |
| AZO | $47.8B | 19.7× | 13.3× | 2.5× | 2.4% | 52.6% | 13.2% | -73.2% | 46.4% | 2.1× | 1,245 |
| CMG | $45.0B | 29.5× | 19.4× | 3.8× | 5.4% | — | 12.9% | 54.3% | 54.3% | 0.0× | 1,203 |
| MED | $131M | — | 1453.4× | 0.3× | -36.0% | 71.3% | -4.8% | -9.4% | -9.4% | — | 113 |
Peers = companies sharing MED's sector (Consumer Cyclical) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.